Cite

HARVARD Citation

    Xie, C. et al. (2021). Benefit and risk of adding rivaroxaban in patients with coronary artery disease: A systematic review and meta‐analysis. Clinical cardiology. 44 (1), pp. 20-26. [Online]. 
  
Back to record